1. Home
  2. ICCC vs GNSS Comparison

ICCC vs GNSS Comparison

Compare ICCC & GNSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ImmuCell Corporation

ICCC

ImmuCell Corporation

N/A

Current Price

$9.74

Market Cap

93.1M

Sector

Health Care

ML Signal

N/A

Logo Genasys Inc.

GNSS

Genasys Inc.

BUY

Current Price

$1.45

Market Cap

77.0M

ML Signal

BUY

Company Overview

Basic Information
Metric
ICCC
GNSS
Founded
1982
1992
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Consumer Electronics/Appliances
Sector
Health Care
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
93.1M
77.0M
IPO Year
1995
1996

Fundamental Metrics

Financial Performance
Metric
ICCC
GNSS
Price
$9.74
$1.45
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
★ $3.87
AVG Volume (30 Days)
12.4K
★ 64.6K
Earning Date
11-12-2026
08-13-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 53.85
44.44
EPS
★ 0.41
N/A
Revenue
★ $26,493,169.00
$26,306,790.00
Revenue This Year
N/A
$39.82
Revenue Next Year
N/A
$12.95
P/E Ratio
$23.78
★ N/A
Revenue Growth
★ 51.64
29.50
52 Week Low
$4.52
$1.39
52 Week High
$12.10
$2.47

Technical Indicators

Market Signals
Indicator
ICCC
GNSS
Relative Strength Index (RSI) 49.44 37.67
Support Level $9.39 $1.40
Resistance Level $10.16 $1.60
Average True Range (ATR) 0.26 0.07
MACD 0.01 -0.00
Stochastic Oscillator 67.27 14.29

Price Performance

Historical Comparison
ICCC
GNSS

About ICCC ImmuCell Corporation

ImmuCell Corp is an animal health biologics company focused on the development, manufacture, and commercialization of products intended to improve the survivability, health, and long-term performance of neonatal dairy and beef calves. Its product, First Defense, utilizes hyperimmunized bovine colostrum to provide pathogen-specific antibodies and other bioactive components. First Defense is designed to provide Immediate Immunity through orally delivered antibodies against the principal viral and bacterial causes of neonatal calf diarrhea (scours), including Escherichia coli (E.coli), bovine coronavirus, and bovine rotavirus. It has two operating segments: Scours and Mastitis. It derives the majority of the revenue from the Scours segment that consists of the First Defense product line.

About GNSS Genasys Inc.

Genasys Inc is a provider of Protective Communication solutions, including Genasys Protect software platform and Long Range Acoustic Device (LRAD). Its software platform receives information from variety of sensors and Internet-of-Things (IoT) inputs to collect real-time information on developing and active emergency situations. Genasys uses this information to create and disseminate alerts, warnings, notifications, and instructions through multiple channels before, during, and after public safety and enterprise threats, critical events, and other crisis situations. The Company operates in two business segments: Hardware and Software and its markets are North and South America, Europe, Middle East and Asia. Key revenue is generated from Hardware.

Share on Social Networks: